Patents by Inventor Daved Henry Fremont

Daved Henry Fremont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY
    Publication number: 20240092854
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to a ligand and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Application
    Filed: June 12, 2023
    Publication date: March 21, 2024
    Inventors: Alexander Sasha Krupnick, Eric Reed Lazear, Daved Henry Fremont
  • Compositions and methods for targeted cytokine delivery
    Patent number: 11897929
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to an NKG2D ligand or PD1 ligand and may improve immunotherapy by limiting side effects associated with immunotherapy. The present disclosure also encompasses compositions and methods for recruiting cytotoxic lymphocytes to target cells using NKG2D receptor ligands or PD1 ligands. The compositions disclosed herein comprise a NKG2D receptor ligand and a targeting molecule and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: February 13, 2024
    Assignee: Washington University
    Inventors: Alexander Sasha Krupnick, Daved Henry Fremont, Eric Reed Lazear, John Westwick
  • Compositions and methods for targeted cytokine delivery
    Patent number: 11713342
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to a ligand and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: August 1, 2023
    Assignee: Washington University
    Inventors: Alexander Sasha Krupnick, Eric Reed Lazear, Daved Henry Fremont
  • COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY
    Publication number: 20210284706
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to an NKG2D ligand or PD1 ligand and may improve immunotherapy by limiting side effects associated with immunotherapy. The present disclosure also encompasses compositions and methods for recruiting cytotoxic lymphocytes to target cells using NKG2D receptor ligands or PD1 ligands. The compositions disclosed herein comprise a NKG2D receptor ligand and a targeting molecule and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Application
    Filed: April 23, 2021
    Publication date: September 16, 2021
    Inventors: Alexander Sasha Krupnick, Daved Henry Fremont, Eric Reed Lazear, John Westwick
  • Compositions and methods for targeted cytokine delivery
    Patent number: 11053293
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to an NKG2D ligand or PD1 ligand and may improve immunotherapy by limiting side effects associated with immunotherapy. The present disclosure also encompasses compositions and methods for recruiting cytotoxic lymphocytes to target cells using NKG2D receptor ligands or PD1 ligands. The compositions disclosed herein comprise a NKG2D receptor ligand and a targeting molecule and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: July 6, 2021
    Inventors: Alexander Sasha Krupnick, Daved Henry Fremont, Eric Reed Lazear
  • COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY
    Publication number: 20210032306
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to a ligand and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Application
    Filed: August 18, 2020
    Publication date: February 4, 2021
    Inventors: Alexander Sasha Krupnick, Eric Reed Lazear, Daved Henry Fremont
  • Compositions and methods for targeted cytokine delivery
    Patent number: 10793613
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to a ligand and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: October 6, 2020
    Inventors: Alexander Sasha Krupnick, Eric Reed Lazear, Daved Henry Fremont
  • COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY
    Publication number: 20190119345
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to an NKG2D ligand or PD1 ligand and may improve immunotherapy by limiting side effects associated with immunotherapy. The present disclosure also encompasses compositions and methods for recruiting cytotoxic lymphocytes to target cells using NKG2D receptor ligands or PD1 ligands. The compositions disclosed herein comprise a NKG2D receptor ligand and a targeting molecule and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Application
    Filed: February 6, 2017
    Publication date: April 25, 2019
    Inventors: Alexander Sasha Krupnick, Daved Henry Fremont, Eric Reed Lazear, John Westwick
  • COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY
    Publication number: 20190092831
    Abstract: The present disclosure encompasses compositions and methods for targeted cytokine delivery. The compositions disclosed herein comprise a cytokine linked to a ligand and may improve immunotherapy by limiting side effects associated with immunotherapy.
    Type: Application
    Filed: December 15, 2015
    Publication date: March 28, 2019
    Inventors: Alexander Sasha Krupnick, Eric Reed Lazear, Daved Henry Fremont